¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hyper-IgM Immunodeficiency Syndrome, Type 1"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
  • dry eye syndrome
    °Ç¼º¾ÈÁõÈıº, ¾È±¸°ÇÁ¶Áõ
  • dumping syndrome
    ºü¸¥ºñ¿òÁõÈıº, ´ýÇÎÁõÈıº
  • defibrination syndrome
    Å»¼¶À¯¼ÒÁõÈıº, Å»ÇǺ기ÁõÈıº
  • deficit syndrome
    °áÇÌÁõÈıº
  • dysarthria clumsy hand syndrome
    Á¶À½Àå¾Ö¼­Å÷¼ÕÁõÈıº
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • Dandy-Walker syndrome
    ´íµð-¿öÄ¿ÁõÈıº
  • dead-in-bed syndrome
    ħ´ë»ç¸ÁÁõÈıº
  • dialysis disequilibrium syndrome
    Åõ¼®ºÒ±ÕÇüÁõÈıº
  • Diamond-Blackfan syndrome
    ´ÙÀ̾Ƹóµå-ºí·¢ÆÇÁõÈıº
  • Down syndrome
    ´Ù¿îÁõÈıº
  • exfoliation syndrome
    ¹ÚÅ»ÁõÈıº
  • ectrodactyly-ectodermal dysplasia clefting syndrome
    °áÁö¿Ü¹è¿±Çü¼ºÀ̻󰥸²ÁõÈıº
  • extrapyramidal syndrome
    ÇǶó¹Ìµå¹Ù±ù±æÁõÈıº, Ãßü¿Ü·ÎÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • clumsy hand syndrome
    ¼­Å÷¼ÕÁõÈıº
  • co-contraction syndrome
    µ¿½Ã¼öÃàÁõÈıº
  • compartment syndrome
    ±¸È¹ÁõÈıº
  • complex regional pain syndrome
    º¹ÇÕ±¹¼Òµ¿ÅëÁõÈıº
  • compression syndrome
    ¾Ð¹ÚÁõÈıº
  • concentration camp syndrome
    ¼ö¿ë¼ÒÁõÈıº
  • congenital constriction ring syndrome
    ¼±ÃµÇùÂø°í¸®ÁõÈıº
  • cor pulmonale syndrome
    Æó½ÉÀåÁõÈıº, ÇãÆÄ½ÉÀåÁõÈıº
  • cord compression syndrome
    ô¼ö¾Ð¹ÚÁõÈıº
  • cranial nerve syndrome
    ³ú½Å°æÁõÈıº
  • craniofacial syndrome
    ¸Ó¸®¾ó±¼ÁõÈıº
  • cri du chat syndrome
    (¢¡cat¡¯s cry) °í¾çÀÌ¿ïÀ½ÁõÈıº
  • cubital tunnel syndrome
    ÆÈ²ß±¼ÁõÈıº
  • culture-bound syndrome
    ¹®È­±ÇÁõÈıº
  • defibrination syndrome
    Å»¼¶À¯¼ÒÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Behcets syndrome
    º£Ã¼Æ® ÁõÈıº
  • Benedikts syndrome
    º£³×µñÆ®ÁõÈıº
  • Blackfan-Diamond syndrome
    ºí·¢ÆÇ-´ÙÀ̾ƸóµåÁõÈıº
  • Bloom syndrome
    ºí·ç¿òÁõÈıº(¡­ñøý¦ÏØ).
  • Briquets syndrome
    ºê¸®ÄÉ ÁõÈıº
  • CREST syndrome
    Å©·¹½ºÆ® ÁõÈıº
  • CRST(Calcinosis, Raynauds phenomenon, Sclerodactyly, Telangiectasia) syndrome
    CRST ÁõÈıº.
  • Cestans syndrome
    ¼¼½ºÅºÁõÈıº.
  • Chandlers syndrome
    îµé·¯ÁõÈıº
  • Charcot-Wilbrand syndrome
    »þ¸£ÄÚ-ºôºê¶õµåÁõÈıº.
  • Charcots syndrome
    »þ¸£ÄÚÁõÈıº.
  • Charlins syndrome
    »þ¸¦·©ÁõÈıº.
  • Chauffard-Still syndrome
    ¼îÆÄ¸£-½ºÆ¿ÁõÈıº.
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½Ã ÁõÈıº
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½ÃÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity, delayed-type
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • hypersensitivity, immediate-type
    Áï½ÃÇü °ú¹Î¹ÝÀÀ
  • hypertrophic type
    ºñ´ëÇü
  • hypogammaglobulinemia, Swiss-type
    ½ºÀ§½ºÇü °¨¸¶±Û·ÎºÒ¸°ÀúÇ÷Áõ
  • intermediate type
    Áß°£Çü(ñéÊàúþ) ¡ìÇãÇ÷¼º Áúȯ(úÈúìàõòðü´)ÀÇ¡í.
  • intracanalicular type
    ¼Ò°ü³»Çü
  • introversion type
    ³»ÇâÇü(Ò®ú¾úþ)
  • intuitive type
    Á÷°üÇü(òÁκúþ)
  • irregular type
    ºÒ±ÔÄ¢Çü
  • jealous type
    ÁúÅõÇü(òì÷àúþ)
  • langhans-type giant cell
    ¶û±×Çѽº°Å´ë¼¼Æ÷, Langerhans °Å´ë¼¼Æ÷(¡­ËÝÓÞá¬øà)
  • lepromatous type
    ³ªÁ¾Çü(ÑÛðþúþ)
  • lepromatous type
    ³ªÁ¾Çü(ÑÛðþúþ).
  • leptosomatic type
    ¸¶¸¥Çü(¡­úþ).
  • limb girdle type
    Áö´ëÇü.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
AIDSDRUGS clinical trials of acquired immunodeficiency drugs [MEDLARS data base]
CVI cardiovascular incident; cardiovascular insufficiency; cerebrovascular incident; cerebrovascular ins...
CVID common variable immunodeficiency
FIV feline immunodeficiency; forced inspiratory volume
GDID genetically determined immunodeficiency disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
type I type B
APS I Autoimmune polyendocrine syndrome type I
APS-1 Autoimmune polyglandular syndrome type 1
CRPS-I Complex Regional Pain Syndrome Type I
EDS IV Ehlers-Danlos syndrome type IV
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anxiety syndrome
    °í¹Î ÁõÈıº, ºÒ¾È ÁõÈıº
    Á¤½ÅÀû °í¹Î¿¡ ¼ö¹ÝÇÏ´Â ÁõÈıºÀ¸·Î, ½É°èÇ×Áø, È£Èí°ï¶õ, ¹ßÇÑ, ¾È»ö â¹é, °øÆ÷ µîÀ» ³ªÅ¸³½´Ù.
  • aortitis syndrome
    ´ëµ¿¸Æ¿° ÁõÈıº
  • apallic syndrome
    ¹«½É ÁõÈıº
  • apathetic-akinetic syndrome
    ¹«°¨µ¿-¹«µ¿ÀÛ ÁõÈıº
  • Apert syndrome
    ¿¡ÆÛÆ® ÁõÈıº, ¾ÆÆä¸£Æ® ÁõÈıº
    ÀÓ»óÀûÀ¸·Î µÎ°³°ñ ºÀÇÕÀÇ Á¶±â Æó¼â·Î ÀÎÇÑ µÎ°³ ±âÇü, ¾È¸é Á߾ӺΠÇü¼º ºÎÀü, ¾çÃø¼º ÇÕÁöÁõÀ¸·Î Á¤ÀǵȴÙ. µå¹® Àå¾Ö·Î¼­ ¶§·Î »ó¿°»öü ¿ì¼º À¯ÀüÀÌ °üÂûµÇ±âµµ Çϳª º¸ÅëÀº »ê¹ßÀûÀÎ µ¹¿¬º¯ÀÌ¿¡ ÀÇÇØ ¹ß»ýµÈ´Ù.
  • arthritis-dermatitis syndrome
    °üÀý¿°-ÇǺο° ÁõÈıº
  • Ashermans syndrome
    ¾Æ¼Å¸¸ ÁõÈıº
    Àڱó» ¿ìÂø¿¡ ÀÇÇÏ¿© Áö¼Ó¼º ¹«¿ù°æ°ú ÀÌÂ÷¼º ºÒÀÓÀÌ ³ªÅ¸³ª´Â °Í. º¸Åë Àڱó» ¼ÒÆÄÀÇ °á°ú·Î ÀϾ´Ù.
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • atypical schizophrenic syndrome
    ºñÁ¤Çü Á¤½ÅºÐ¿­¼º ÁõÈıº
  • autoerythrocyte sensitization syndrome
    ÀÚ°¡ ÀûÇ÷±¸ °¨ÀÛ ÁõÈıº
    ÁÖ·Î ÀþÀº ¿©ÀÚ¿¡°Ô º¼ ¼ö ÀÖ´Â ÀÚ¹Ý ¹ÝÀÀÀÇ ÀÏÁ¾À¸·Î ¿Ü»ó ¾øÀÌ ¶Ç´Â ºÒ¿ÏÀü ¿Ü»ó ÈÄ ½Åü¿¡ ÀÚ¿¬ÀûÀ¸·Î µ¿ÅëÀ» µ¿¹ÝÇÏ°í ¹Ýº¹ÇÏ¿© ´Üµ¶ ¶Ç´Â ´Ù¹ß¼º ¹Ý»ó ÃâÇ÷ÀÌ ³ªÅ¸³­´Ù. ¸¹Àº Áõ·Ê¿¡¼­ ÀûÇ÷±¸ ±¸¼º ¼ººÐ¿¡ ´ëÇÑ °ú¹Î¼ºÀÌ ¿øÀÎÀ¸·Î »ý°¢µÇ³ª, ¹éÇ÷±¸°¡ ¿øÀÎÀ¸·Î »ý°¢µÇ´Â ¿¹µµ ÀÖ´Ù. Á¤¼­Àû Àå¾Ö°¡ ¹ßº´ °á½Ç ÀÎÀÚ·Î º¸ÀδÙ.
  • Axenfeld syndrome
    ¾Ç¼¾ÆçÆ® ÁõÈıº
  • B-K mole syndrome
    B-K ¸ð¹Ý ÁõÈıº
  • Barters syndrome
    ¹ÙÅÍ ÁõÈıº
  • basal ganglion calcification syndrome
    ±âÀú ½Å°æÀý ¼®È¸È­ ÁõÈıº
  • battered child syndrome
    ÇÇÇÐ´ë¾Æ ÁõÈıº, ¾Æµ¿ Çдë ÁõÈıº, ¼Ò¾Æ Çдë ÁõÈıº
    ¾Æµ¿ÀÇ »À ¹× ¿¬ºÎ Á¶Á÷¿¡ ´Ù¼öÀÇ ¿Ü»ó¼º º´º¯À» ³ªÅ¸³»´Â °ÍÀ¸·Î¼­ Á¾Á¾ °æ¸·ÇÏ Ç÷Á¾À» ¼ö¹ÝÇÑ´Ù. ÀÌ·± º´º¯Àº º¸Åë ¼ºÀÎÀÇ °íÀÇÀûÀÎ °¡ÇØ¿¡ ÀÇÇØ »ý±ä´Ù. ºÎ¸ðµéÀÌ 3¼¼ ÀÌÇÏ Æ¯È÷ 1¼¼ ÀÌÇÏÀÇ À¯¾Æ¸¦ ¹«ºÐº°ÇÏ°Ô ¶§¸®°Å³ª ±âŸ ¹æ¹ýÀ¸·Î ÇдëÇÔÀ¸·Î½á ÀϾ´Â ½Åü Áõ»ó. ¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ»ç H. ÄÍÇÁ µîÀÌ ¹Ì±¹ Àü¿ª¿¡ °ÉÃÄ Á¶»çÇÏ¿´À¸¸ç, 1962³âÀÌ·¡ ¼±Áø Á¦±¹¿¡ ³Î¸® ¾Ë·ÁÁø Çö»óÀÌ´Ù. ÁÖ·Î, ¨ç ÇÇÇÏ ÃâÇ÷, Àý»ó, È­»ó µîÀÇ ÇǺΠÁõ¼¼, ¨è Àü½ÅÀÇ °ñÀý, Å»±¸, ¨é µÎ°³³» ÃâÇ÷À̳ª °æ¸·ÇÏÇ÷Á¾, ¨ê Àå±â ÆÄ¿­ ¹× ³»ÃâÇ÷ µî º¹ºÎÀÇ ¼Õ»ó, ¨ë ¼ºÀå ¹ß´Þ ÀåÇØ µîÀ» º¼ ¼ö ÀÖ´Ù. À̰ÍÀº ¿À´Ã³¯ÀÇ ¼±Áø Á¦±¹ÀÇ ±Þ¼ÓÇÑ °¡Á¤ ºØ±« Çö»ó°ú °ü·ÃÇÏ¿© ÀϾ´Â Áõ¼¼ÀÌ´Ù. ºÎºÎ°£ÀÇ °¥µîÀÌ ±Ø½ÉÇØÁö¸é À̵éÀº ¼­·Î °£ÆíÇÏ°Ô Çì¾îÁ®¾ß ÇÑ´Ù°í »ý°¢Çϰí À̶§ ¾î¸°¾ÆÀ̵éÀÌ Àå¾Ö¹°À̶ó ¹Ï°Ô µÇ¾î ¾Æ¹« ÁË ¾ø´Â ¾ÆÀ̵éÀ» ¸¶±¸ ÆøÇàÇÏ´Â µîÀÇ ÇдëÇàÀ§°¡ ³ªÅ¸³­´Ù. Çд븦 °¡ÇÏ´Â ºÎ¸ðµéÀº Á¤¼­ÀûÀ¸·Î ¹Ì¼÷ÇÑ È÷½ºÅ׸® ¼º°ÝÀÚ, ¼ºÀû ºÒ°¨Áõ, °ø°Ý¼º ¼º°ÝÀÚ, ¾ËÄÚ¿Ã Áßµ¶ÀÚ, ¸Á»óÇüÀÇ Á¤½ÅºÐ¿­Áõ ȯÀÚ µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. À̶§ Çд븦 ¹ÞÀº ¾ÆÀ̵éÀº Á¤½Å ¹ß´Þ Àå¾ÖÁõ, ¹ÝÇ×Àû ¼º°Ý, °íÁýÀÌ ¼¾ Ç×¹®±âÀû °íÂøÁõ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù. ÀÌ·¯ÇÑ Çö»óÀº Çѱ¹ÀÇ »çȸ ¹®È­¿¡¼­´Â ¾ÆÁ÷ Èñ±ÍÇÏÁö¸¸ ±Ù´ëÈ­, ÇÙ°¡Á·È­, ¿©±ÇÀÇ ½ÅÀå, ¾ËÄÚ¿Ã Àα¸ÀÇ Áõ°¡, »çȸÀû ½ºÆ®·¹½º ¿äÀÎÀÇ Áõ´ë·Î Á¡Á¡ Áõ°¡µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
Naegeli type of monocytic leukaemia A variant of granulocytic leukaemia with monocytosis in the peripheral blood.
Synonym: Naegeli type of monocytic leukaemia.
(05 Mar 2000)
name bearing type <zoology> The type genus, type species, holotype, lectotype, series of syntypes, neotype, type slide, or hapantotype, that provides the objective standard of reference whereby the application of the name of a taxon can be determined.
(09 Jan 1998)
neoplasms by histologic type A collective term for the various histological types of neoplasms. It is more likely to be used by searchers than by indexers and catalogers.
(12 Dec 1998)
stream-type fish Fish that rear for a year or more in a stream.
(09 Oct 1997)
Nezelof type of thymic alymphoplasia Synonym: cellular immunodeficiency with abnormal immunoglobulin synthesis.
(05 Mar 2000)
s-type cholinesterase <enzyme> An enzyme that breaks down acetylcholine tostop its action.
(22 May 1997)
S type lectin <protein> One of two classes of lectin produced by animal cells. The classification of animal lectins into two classes, the other being the C type, was originally proposed by K.Drickamer.
The carbohydrate binding activity of the S type lectins requires their cysteines to have free thiols and does not need divalent cations (c.f. C type lectins). They mostly have molecular masses in the range 14-16 kD and often form dimers and higher oligomers. The carbohydrate recognition domain contains a number of critically conserved amino acids and largely binds to _ galactosides. S type lectins certainly occur as cytoplasmic proteins but the existence of extracellular S type lectins is still a matter of debate.
(18 Nov 1997)
nomenclatural type The constituent element of a taxon to which the name of the taxon is permanently attached; the type of a species is preferably a strain (in special cases it may be a description, a preserved specimen or preparation, or an illustration); the type of a genus is a species; and the type of an order, family, or tribe is the genus on whose name the name of the higher taxon is based.
(05 Mar 2000)
nutritional type cerebellar atrophy A restricted type of cerebellar cortical degeneration, affecting particularly the Purkinje cells of the anterior and superior vermis; probably caused by thiamin deficiency; most frequently seen in chronic alcoholics and then called alcoholic cerebellar degeneration.
(05 Mar 2000)
delayed type hypersensitivity <immunology> Hypersensitivity (increased reaction by the body to a foreign substance such as an antigen or allergen) that does not appear until 24 to 48 hours after the body is exposed to the foreign substance.
(09 Oct 1997)
Swiss type agammaglobulinaemia Group of rare congenital disorders characterised by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an x-linked or autosomal recessive defect. About half of the patients with autosomal recessive scid are deficient in the enzyme adenosine deaminase.
(12 Dec 1998)
deoxyribonucleases, type III site-specific <enzyme> Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as atpases. They exist as complexes with modification methylases of similar specificity.
The systems recognise specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.5
(12 Dec 1998)
deoxyribonucleases, type II site-specific <enzyme> Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognise specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.4
(12 Dec 1998)
deoxyribonucleases, type I site-specific <enzyme> Enzyme systems containing three different subunits and requiring ATP, s-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent atpases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognise specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.3
(12 Dec 1998)
diabetes, type 1 Insulin dependent diabetes or juvenile diabetes.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á